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ABSTRACT
Endocannabinoid-Dependent Long-Term Depression of
Ventral Tegmental Area GABA Neurons
Jared Mark Weed
Department of Physiology and Developmental Biology, BYU
Master of Science
GABA neurons in the ventral tegmental area of the midbrain are important components
in the brain's reward circuit. Long term changes in this circuit occur through the process of
synaptic plasticity. It has been shown that high frequency stimulation, as well as treatment with
endocannabinoids, can cause GABA neurons in the ventral tegmental area to undergo long term
depression, a form of synaptic plasticity that decreases excitability of cells. The present study
elaborates on the mechanism whereby high frequency stimulation can result in long term
depression of ventral tegmental area GABA neurons. Using the whole cell patch clamp technique
in acute brain slices, we recorded excitatory currents from ventral tegmental area GABA neurons
in GAD-GFP expressing CD1 mice and observed how the excitatory currents changed in
response to different treatments. We confirm that high frequency stimulation causes long term
depression, and the cannabinoid type 1 receptor antagonist AM-251 blocks this effect. Long term
depression is also elicited by treatment with the cannabinoid type 1 receptor agonist 2arachidonylglycerol. It is inconclusive whether treatment with 2-arachidonylglycerol occludes
further long term depression by high frequency stimulation. We also demonstrate that activation
of group I metabotropic glutamate receptors by DHPG produces long term depression. These
results support the model that at these excitatory synapses, high frequency stimulation causes the
release of glutamate from presynaptic terminals, activating group I metabotropic glutamate
receptors, causing production of 2-arachidonylglycerol. 2-arachidonylglycerol in turn acts on
presynaptic cannabinoid type 1 receptors to decrease release of glutamate onto GABA neurons.
This model can be tested by further research, which should include cannabinoid type 1 receptor
knockout mice. This study provides more insight into how drugs of abuse such as
tetrahydrocannabinol, the active component of marijuana that activate cannabinoid type I
receptors, can corrupt the natural reward mechanisms of the brain.
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INTRODUCTION
Addiction is a disorder in which an organism’s natural reward system is usurped by
substances or behaviors. The effects of addiction have a negative impact on both society and
individuals. As of 2010, an estimated 23.1 million Americans were in need of treatment related
to drug or alcohol abuse (Substance Abuse and Mental Health Services Administration, 2010). In
cases of severe addiction, drug abusers may neglect their basic survival needs and even behave
recklessly in order to obtain drugs. Indeed, a large proportion of crimes in the United States
involve drugs directly, are committed in order to obtain drugs, or are committed while under the
influence of psychoactive substances (Dorsey, Zawitz, & Middleton, 2005; Reedt & Reimer,
2012). The ramifications of addictive behavior highlight the need for the reward system to be
understood at neural network, cellular, and molecular levels.
The Mammalian Reward System
Highly evolved organisms have developed sophisticated reward systems to enhance the
chances for the survival of their species. For humans, this system promotes goal-directed
behaviors that meet dietary and sexual needs. It also allows humans to adapt to an environment
by attaching salience to novel rewarding stimuli and by mediating feelings of pleasure. The exact
neural correlates for these various functions of the reward system are debatable, but the
mesocorticolimbic dopamine system is key to our current understanding of how reward is
processed in the brain (Robinson & Berridge, 2008; R. Wise, 2008).
The Mesocorticolimbic System
The mesocorticolimbic system is comprised of the ventral tegmental area (VTA) of the
midbrain and its principal targets: the nucleus accumbens, the prefrontal cortex, the amygdala,
and the hippocampus (Kent C Berridge, 2007; Kelley, 2004). The rodent VTA consists of cells
1

that produce dopamine (DA) (55%), cells that produce gamma-amino butyric acid (GABA)
(23%), and cells that produce glutamate (up to 22%)(Margolis, Toy, Himmels, Morales, &
Fields, 2012). In response to rewarding stimuli, VTA DA cells release DA into the VTA and its
projections. This increase of DA can be elicited by natural reward stimuli as well as by drugs of
abuse (Fields, Hjelmstad, Margolis, & Nicola, 2007; Schultz, 1998). Rats will compulsively selfadminister drugs of abuse directly into the VTA, and goal-directed behaviors can be blocked by
intracranial VTA DA depletion via 6-hydroxydopamine (K C Berridge & Robinson, 1998;
McBride, Murphy, & Ikemoto, 1999). Furthermore, rats will also self-stimulate by pushing a
lever that causes current to pass through an electrode intracranially placed into the VTA (R. a
Wise, 1996).
Cellular Mechanisms of Reward
At the cellular level, different drugs of abuse have different mechanisms of action, but
they share the common effect of increasing the amount of DA present at synapses of
dopaminergic cells. Cocaine acts by blocking DA transporters (DATs), preventing re-uptake of
DA and keeping it in the synaptic cleft. Methamphetamine more potently increases synaptic DA
levels by causing DATs to reverse transport DA into the synapse itself. Nicotine acts on all cells
in the VTA to increase dopaminergic neuron firing rates. Ethanol has broad effects in the CNS,
so its mechanism in the DA system is not as defined. Δ9-tetrahydrocannabinol (THC), the active
component in marijuana, acts on cannabinoid receptor 1 (CB1) in the VTA to attenuate the
inhibitory inputs of GABA neurons on DA neurons. (Pierce & Kumaresan, 2006)This releases
dopamine neurons from inhibitory regulation, or disinhibits them, allowing them to release more
dopamine.
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Synaptic Plasticity: A mechanism for long-term changes in brain circuitry
These aforementioned mechanisms help to explain the immediate actions of drugs of
abuse on reward, but fail to account for the long-term addictive effects of drug use. The study of
synaptic plasticity, the neuronal basis for long-term connection changes in the brain, has helped
to elucidate how these long-term changes happen in the mesocorticolimbic system. Synaptic
signaling can be strengthened through processes of long term potentiation (LTP) or weakened
through processes of long term depression (LTD). Synaptic plasticity can occur by high levels of
calcium entry via activated N-Methyl-D-Aspartate glutamate receptors (NMDARs), resulting in
post-synaptic LTP, in which non-NMDA glutamate receptors are trafficked to the synapse.
Alternatively, either low levels of calcium entry via activated NMDARs or activation of mGluR1
can result in post-synaptic LTD, in which non-NMDA receptors are internalized (Malenka &
Bear, 2004). Presynaptic LTD can also occur, most commonly via presynaptic cannabinoid (CB)
receptors. In response to stimulation of mGluR1/5 receptors, the postsynaptic neuron
manufactures endocannabinoids (eCBs) such as anandamide or 2-arachidonoylglycerol (2-AG),
which retrogradely activate CB receptors and cause less presynaptic neurotransmitter release
(Kauer & Malenka, 2007). Another type of presynaptic LTD, which has been shown to operate
in the hippocampus, occurs via the TRPV1 channel. Unlike CB receptors, which are
metabotropic, the TRPV1 channel is ionotropic and conducts Ca2+ ions which can act as second
messengers in the presynaptic terminal to decrease neurotransmitter release (Gibson, Edwards,
Page, Van Hook, & Kauer, 2008; Jensen & Edwards, 2012).
Synaptic Plasticity in the Mesocorticolimbic System
NMDAR-mediated synaptic plasticity has been well studied in the mesocorticolimbic
system, and especially on dopaminergic cells. Early evidence that synaptic plasticity was
3

involved in the mesocorticolimbic system was that co-administration of the NMDA receptor
antagonist MK-801 with amphetamine in the ventral striatum of rats failed to induce the
behavioral sensitization to amphetamine that the control rats displayed (Wolf, White, & Hu,
1994). In the VTA, nicotine-induced LTP of glutamatergic-dopaminergic synapses was blocked
by the NMDAR antagonist APV (Mansvelder & McGehee, 2000). Soon after, it was shown that
mouse VTA Dopaminergic cells undergo potentiation that lasts 5 days after a single in vivo
exposure to cocaine, and this potentiation can be prevented by co-administration of MK-801
(Ungless, Whistler, Malenka, & Bonci, 2001). It was further demonstrated that this form of
plasticity required the action of the endogenous molecule orexin, which is elsewhere involved
with feeding behavior (Borgland, Taha, Sarti, Fields, & Bonci, 2006). These results together
demonstrate that NMDAR-mediated LTP operates in the mesocorticolimbic system in both
normal reward function and in the addictive state.
Synaptic activity in VTA DA neurons can also be modulated by eCBs. eCBs work in
conjunction with D2 receptor activation to produce depolarization-induced suppression of
excitation (DSE) at glutamatergic synapses on DA cells (Melis et al., 2004). Consistent with this
observation, it was recently found that eCB signaling inhibited induction of LTP of DA cells,
and this inhibition was blocked in the presence of CB1 antagonists (Kortleven, Fasano, Thibault,
Lacaille, & Trudeau, 2011). It has also been shown that LTD at inhibitory synapses can be
elicited by cocaine administration paired with 10 Hz stimulation, and this inhibitory LTD (ILTD) can be blocked by the CB1 receptor antagonist AM-251 or in CB1 knockout mice. This
eCB-mediated I-LTD depended on both D2 receptor and group I mGluR activation, as would be
expected for an eCB-dependent pathway (Pan, Hillard, & Liu, 2008a). Further study showed that
D2 receptor activation blocks neurotransmitter release via presynaptic protein kinase A (PKA)
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signaling. PKA signaling occurs downstream of CB1 activation, so somehow D2 activation is
able to modulate CB1 receptor activity to facilitate the increase in presynaptic PKA signaling
(Pan, Hillard, & Liu, 2008b). These findings collectively show that both excitatory and
inhibitory transmission onto VTA dopaminergic cells can be modified via eCB activity.
Involvement of VTA GABA Neurons in the Mesocorticolimbic System
However, while VTA DA neurons have been abundantly researched, VTA GABA
neurons have been largely ignored until recently. As excitement about researching these neurons
has increased, researchers have discovered how they play an important part in the
mesocorticolimbic reward system. Compelling evidence suggests that VTA GABA neurons are
responsible for the brain stimulation reward response seen in the self-stimulation paradigm in
rats (Lassen et al., 2007). It was further found that optogenetic activation of VTA GABA
neurons inhibits VTA DA neurons and precludes attenuates reward consumption in mice (van
Zessen, Phillips, Budygin, & Stuber, 2012). Optogenetic activation of VTA GABA neurons also
facilitates conditioned place aversion (Tan et al., 2012).
The GABA neurons in the VTA are locally connected together via gap junctions (Allison
et al., 2006), and regulate activity of both local DA neurons and project to neurons in other areas
of the mesocorticolimbic system (van Zessen et al., 2012). Synaptic plasticity in VTA GABA
neurons is not well-studied, but inroads are being made to understand the process. It was recently
shown that methamphetamine administration in mice causes GABAB receptors and G proteingated inward rectifying potassium (GIRK) channels to be internalized in VTA GABA cells,
causing the neurons to become more excitable (Padgett et al., 2012). As the study of VTA
GABA neurons becomes easier, more mechanisms governing plasticity of these neurons will be
uncovered.
5

Involvement of Endocannabinoids in VTA GABA Neuron Plasticity
Unpublished data collected in this lab show that eCBs play an important part in the
synaptic plasticity of VTA GABA neurons. Using mice that were engineered to co-express
glutamic acid decarboxylase 67 (GAD67) and green fluorescence protein (GFP) (Tamamaki et
al., 2003), it was shown that these GABA neurons exhibit LTD in excitatory currents in response
to high frequency stimulus (HFS) in brain slices. This LTD was also elicited by bath application
of the endocannabinoid and CB1 agonist R-methanandamide, and this drug occluded further
LTD by subsequent HFS. To rule out another possible endocannabinoid receptor, TRPV1, it was
demonstrated that the TRPV1 antagonist capsazepine failed to block LTD.
Mechanisms of LTD in VTA GABA Neurons
These findings give a clearer picture of how synaptic plasticity occurs in VTA GABA
cells, but more research needs to be done to further characterize the pathways at work in these
synapses. The present study shows that CB1 activation with 2-arachidonylglycerol (2-AG)
causes LTD in VTA GABA neurons, most likely in a presynaptic manner. However, long-term
CB1 activation with 2-AG does not prevent additional HFS-LTD from occurring. We also show
that activation of type I mGluRs with DHPG results in LTD of VTA GABA neurons. Although
CB1 activation may not be completely responsible for the effects of HFS-LTD, it is necessary for
HFS-LTD to occur. Because type I mGluR activation can lead to eCB production such as 2-AG,
mGluRs provide a plausible mechanism whereby HFS can lead to CB1 receptor-mediated LTD.
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MATERIALS AND METHODS
Slice Preparation
GAD67-GFP mice were anesthetized using isofluorane and decapitated. The brain was
quickly removed and horizontal slices 220um thick were obtained using a vibratome. Slices were
cut at the level of the anterior commissure in Artificial Cerebrospinal Fluid (ACSF) containing in
mM: 220 Sucrose, 3KCl, 1.25 NaH2PO4, 25 NaH2CO3, 12 MgSO4, 10 dextrose, 0.2 CaCl2,
saturated with 95% O2/5% CO2 (pH 7.3). After sectioning slices were removed and incubated in
ACSF containing 119 NaCl, 26 NaHCO3, 2.5 KCl, 1.0 NaH2PO4, 2.5 CaCl2, 1.3 MgSO4 and
11 dextrose, saturated with 95% O2/5% CO2 (pH 7.4) warmed to 37 °C for at least 30 minutes.
Slices were then incubated for at least one hour at room temperature before being transferred to
the recording chamber.
Electrophysiology
When transferred to the recording chamber brain slices were continuously perfused with
oxygenated ACSF warmed to 32-34 °C. Recording electrodes were obtained using a Model P1000 Flaming/Brown Micropipette Puller. The resistances of recording pipettes were kept
between the values of 2-4Mohms. Recording pipettes were filled with an intracellular solution
consisting of in mM: 117 cesium gluconate, 2.8 NaCl, 5 MgCl2, 20 HEPES, 2 ATP, 0.3 GTP, 1
QX-314, and 0.6 EGTA. In all experiments picrotoxin (100 μM) was added to the ACSF bath in
order to block GABAA receptors. The VTA was identified as immediately lateral to the
fasciculus retroflexus in horizontal slices at the level of the anterior commissure. In EPSC
experiments a bipolar stainless steel stimulating electrode was placed in proximity of fluorescent
GABA neurons in order to activate local axon terminals. EPSCs were invoked at 0.1Hz with a
paired pulse 50ms apart. Fluorescent neurons were patched in the whole cell configuration and
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clamped at -65mV. EPSCs were recorded and amplified using an axoclamp 700B amplifier
(axon instruments), and low-pass filtered at 4 kHz. Amplified EPSCs were digitally sampled to a
PC at 20kHz using pClamp 10.2 Clampex software (Molecular Devices). The input resistance
and series resistance were recorded throughout the experiments. If input resistance changed by
more than 10% during the experiment it was discarded. GAD67-GFP cells were identified using
an Olympus USH-1030S fluorescent light source.
Drugs
AM-251, 2-AG, and DHPG were purchased from Tocris Bioscience. AM-251 and 2-AG
were dissolved in DMSO (not more than 0.1% DMSO in final solution), and DHPG was
dissolved directly into the ACSF used for experiments. Picrotoxin was purchased from Tocris
Bioscience and was present in ACSF at a concentration of 100 μM in order to isolate excitatory
currents in the recorded cells. To confirm isolation of glutamate-gated excitatory currents, APV
(Tocris Bioscience) and CNQX (Abcam Inc.) were used in order to block glutamate receptors.
Data Analysis
EPSC amplitudes were measured relative to pre-stimulation baseline currents for each
sweep recorded from the cell. The EPSC amplitudes were obtained from raw data using pClamp
10.2 Clampfit software (Molecular Devices). EPSC amplitudes from 6 sweeps were averaged
together into 1-minute bins, and were normalized to the amplitudes obtained during the 5
minutes before conditioning. To determine whether the EPSC amplitudes significantly differed
between pre-conditioning and post-conditioning epochs, a two sample (unequal variance) twotailed t-test was performed. The averages of the normalized EPSCs were compared between the
last five minutes of the pre-conditioning epoch and minutes 16-20 of the post-conditioning
epoch. Statistical significance was determined with an α level of 0.05. 95% Confidence intervals
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are reported using standard error as the measure of variability. All calculations were performed
using Microsoft Excel and graphs were created using Origin 7.5.
Paired pulse ratio (PPR; EPSC2/EPSC1) and coefficient of variation (CV) analysis was
performed for several sets of experiments. Experiments in which EPSC amplitude was depressed
by more than 10% were included in PPR and 1/CV2 analysis (Gibson et al., 2008). For each
experiment to be analyzed, PPR and CV were calculated within 5-minute epochs of 30 EPSCs
each. The first epoch was the 5 min immediately prior to conditioning and the second epoch was
between 14-19 minutes. PPR for each epoch was calculated by dividing EPSC2 from the paired
pulse by EPSC1. 1/CV2 was calculated for each epoch by dividing the squared mean EPSC
amplitude by the variance of the EPSC amplitudes. Because the results obtained were not
normally distributed, distribution-free nonparametric inferential statistics were used to determine
significance. The Wilcoxon matched-pairs signed-ranks test was performed using JMP statistical
analysis software, and significance was determined using an α level of 0.05.
Statement of Animal Model
Male CD1 mice (ages: p18-p24) expressing GFP on the GAD67 promoter were used in
order to distinguish GABA neurons from other neuron types in the VTA (Tamamaki et al.,
2003). The VTA lacks the easily identifiable structure of other well-studied brain areas in
plasticity, such as the hippocampus and cerebellum. Using these GAD-GFP mice, we were able
to easily tell which cells produced GABA by detecting fluorescence from the GFP that was
concurrently produced in GABA cells in this breed of mice. It is possible that affixing GFP to
one of the GAD67 alleles may reduce expression of GAD67, resulting in a decreased level of
GABA production (unpublished data). Nevertheless, the effects of this possible defect were
diminished by the fact that only excitatory (non-GABAA) currents are recorded in this study.
9

RESULTS
Recorded EPSCs Stay Constant with Time and Are Generated by Glutamate-gated Ion Channels
Recording from cells using the whole cell patch clamp technique could potentially
weaken cellular health over time. A rundown effect may be observed in EPSC amplitudes over
time as a result. Because we were examining LTD, the rundown effect potentially may have
biased our results towards LTD. In addition, many experiments entailed measuring differences in
EPSCs in response to switching from a control solution (ACSF with 100 μM picrotoxin) to a
solution with a conditioning drug. Switching between solutions potentially introduces
confounding factors (such as bubbles generated from the switching process or from differences
in solution temperatures or oxygen saturation) that can also bias the results.
To correct for these potential confounders, a rundown experiment was performed in
which slices were bathed in control ACSF and after achieving a 5-minute baseline of recording
EPSCs, the bath solution was switched to a different container containing the same ACSF. The
experiment continued for as long as the cell opening remained intact. 40 minutes after switching
the bath solution, the EPSC amplitudes showed minimal signs of rundown (Figure 1A).
Next, we wanted to confirm that EPSCs were indeed glutamate mediated and not by
another neurotransmitter. After obtaining a baseline recording in control ACSF, the AMPAR
antagonist CNQX (10 μM) and NMDAR antagonist APV (50 μM) were added to the bath for 10
minutes to block ionotropic glutamate receptors. Within two minutes of applying the glutamate
receptor antagonists, EPSC amplitudes were extinguished (Figure 1B). After reapplying control
ACSF to the bath, EPSC amplitude recovered slowly to above 50%. This showed that the EPSCs
obtained in the control ACSF were solely mediated by ionotropic glutamate receptors.
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High Frequency Stimulation Causes LTD in VTA GABA Neurons
Synaptic plasticity can be mediated by many different mechanisms, and is often achieved
in response to changes in frequencies of neuronal activation. High frequency stimulation (HFS)
is a well-known method of inducing both LTP and LTD. In the CA1 region of the hippocampus,
HFS has is able to cause LTD in stratum radiatum interneurons and LTP in pyramidal cells
(McMahon & Kauer, 1997). In the VTA, HFS (2 pulses of 100 Hz for 1 sec intervals given 20
seconds apart) has been shown to induce LTP in field potentials (Nugent, Hwong, Udaka, &
Kauer, 2008). Prior research performed in this lab identified that high frequency stimulation
causes LTD in VTA GABA neurons, and subsequent experiments have confirmed this effect
(Figure 2A). The data we obtained demonstrate a significant difference in EPSC amplitudes due
to HFS (p=0.0098; 95% C.I.: 18.1±3.2%; n=17).
Changes in paired pulse ratio (PPR) and coefficient of variation (CV) concomitant with
LTD indicate a presynaptic mechanism for plasticity. In 7 of 9 cells analyzed the PPR increased
and in 8 of 9 cells 1/CV2 decreased (Figure 2B). This is highly suggestive of a presynaptic
mechanism, but the difference is not statistically significant (PPR: p=0.203, n=9; 1/CV2:
p=0.074, n=9).
CB1 Receptor Antagonist AM-251 Blocks HFS-LTD
Our research demonstrates that VTA GABA neurons not only undergo LTD in response
to HFS, but also in response to cannabinoids. We found that R-methanandamide (an agonist for
CB1, TRPV1 and other putative eCB receptors) caused LTD. To see if this effect was mediated
by TRPV1, HFS-LTD was attempted in the presence of the TRPV1 antagonist capsazepine (10
μM). It was found that LTD still occurred in the presence of capsazepine (Figure 3; p=0.016,
95% C.I.: 0.094±0.072%, n=9). Blockade of CB1 receptors with AM-251 (2 μM), however,
11

showed a link between cannabinoids and HFS-LTD (Figure 4). Attempting HFS-LTD failed in
the presence of AM-251 (p=0.81; 95% C.I.: 2.4±21.5%; n=3). This suggests that CB1 receptor
activation is required for HFS-LTD in VTA GABA neurons.
CB1 Receptor Agonist 2-Arachidonylglycerol Causes LTD, but Does Not Occlude HFS-LTD
While CB1 receptors may be required for HFS-LTD, we wanted to see whether CB1
activation alone was sufficient for LTD. We made sure to choose an agonist that was not only
specific to the CB1 receptor, but is also found endogenously in the VTA. RT-PCR analysis in
our lab (unpublished data) shows that VTA GABA neurons express DAG lipase, an enzyme that
is required for the production of the eCB 2-arachidonylglycerol (2-AG). Because 2-AG is
plausibly manufactured by VTA GABA neurons, we attempted to achieve LTD via 2-AG
application. We found that applying 2-AG (25 μM) to the bath for 10 minutes elicits moderate
but significant LTD (Figure 5A; p=0.035; 95% C.I.: 22.0±7.8.0%; n=6). PPR analysis showed
that each of the 4 analyzed cells exhibited an increase in PPR and decrease in 1/CV2 (Figure 5B).
Not enough experiments were analyzed, however, to establish statistical significance (p=0.125;
n=4 for both PPR and 1/CV2). While the current evidence suggests a presynaptic mechanism for
2-AG mediated LTD, replication of these results is needed to establish statistical significance.
Because the results of the AM-251 experiments suggest that CB1 activation is required
for HFS-LTD, we attempted to see if LTD caused by 2-AG application occludes further HFSLTD. Acute brain slices were incubated in 50 μM 2-AG to saturate CB1 receptors, then
maintained CB1 receptor activation in the recording bath by perfusing the slices with ASCF
containing 25 μM 2-AG. Not enough full-length experiments were obtained to perform statistical
analysis, but initial results show that 2-AG does not fully occlude HFS-LTD (Figure 6).
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Type I mGluR Agonist DHPG Causes LTD
According to our results (especially our AM-251 results), it is plausible that HFS can
cause release of 2-AG from VTA GABA neurons to result in presynaptic LTD. Metabotropic
glutamate receptors (mGluRs) are viable candidates for transducing this signal because when
activated they can stimulate phospholipase C (PLC), resulting in the precursor molecule for 2AG production (Hashimotodani, Ohno-Shosaku, Watanabe, & Kano, 2007; Rao, Hatcher, &
Dempsey, 2000). To test this possibility, we measured the effect of 10 minutes of bath DHPG
application (100 μM) on EPSC amplitude in VTA GABA neurons. Application of DHPG results
in quick and robust LTD (Figure 7A; p=0.0019; 95% C.I.: 34.7±8.3%; n=5). This LTD coincided
with an increase in PPR in 3 of 4 analyzed cells and a decrease in 1/CV2 in all 4 cells (Figure
7B). Although these differences in PPR and 1/CV2 were not statistically significant (PPR:
p=0.250, n=4; 1/CV2: p=0.125, n=4), this does not rule out a presynaptic mechanism of LTD.
Further experiments may establish statistical significance.
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DISCUSSION
Plasticity in VTA GABA Cells
We report that HFS in the VTA causes LTD of excitatory currents in GABA neurons.
This provides new and perhaps unprecedented information in the context of previous plasticity
research performed in the VTA. For at least 14 years, HFS protocols have been used in the VTA
to examine plasticity of DA and GABA neurons. However, only two other studies that we know
of have examined synaptic plasticity of excitatory synapses onto GABA cells. In one study a
pairing protocol (+10 mV, 200 stimuli at 1 Hz) failed to induce either LTP or LTD (Bonci &
Malenka, 1999). We report here that a different protocol, HFS (2 trains of 100 Hz for 1s, each
train 20s apart) does in fact cause depression of EPSCs in VTA GABA neurons. This is a novel
type of synaptic plasticity never before identified. In another study HFS caused NMDARdependent LTP of VTA field potentials and in VTA DA neurons though HFS did not produce
either LTP or LTD in VTA GABA neurons (Nugent et al., 2008). This contradicts the principle
finding of our investigation. This discrepancy can’t be explained by a difference in stimulation
protocol because both groups used identical HFS protocols, and this can’t be explained by
circuit-wide effects of ionotropic receptor antagonists, because picrotoxin (100 μM) was present
in the bath in both sets of experiments. One main difference is that our data were the result of 17
HFS experiments whereas Nugent et al. analyzed 4 experiments, and in fact we do not see LTD
in every single GABA cell. Another potential difference is that each group could have been
recording from different populations of neurons. For our experiments, we defined the VTA as
lateral to the fasciculus retroflexus, which could be a different area from where Nugent et al.
collected their data. Furthermore, we used genetic methods to positively identify VTA GABA
neurons, whereas Nugent et al. used Ih current to distinguish between DA neurons and non-DA
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neurons (that were assumed to be GABAergic), which has since been reported as a poor way to
distinguish between GABA and DA neurons (Chieng, Azriel, Mohammadi, & Christie, 2011).
Therefore, our data of positively identified GABA neurons we feel confirm that indeed LTD of
EPSCs is exhibited by VTA GABA neurons in response to HFS.
Plasticity of GABAergic Synapses and Disinhibition
We theorize that LTD of VTA GABA neurons would cause reduced GABA release onto
VTA DA neurons, which we term as disinhibition. Our examination of excitatory input on VTA
GABA neurons fit this inhibition model. Several other studies have examined plasticity of inputs
to GABA and DA neurons, which can be compared to our overall finding that GABA cells have
depressed excitatory input in response to HFS. For example, Nugent et al. reported that HFS (the
same protocol used in our study) caused LTP of GABAA currents, albeit onto DA neurons rather
than GABA neurons, in a presynaptic and heterosynaptic fashion, and that this LTPGABA could be
blocked by in vitro or in vivo administration of morphine (Nugent, Penick, & Kauer, 2007).
This finding of Nugent et al. (2007) does not necessarily fit with the disinhibition model
that we describe is at work in the VTA. It should be noted, however, that in order for Nugent et
al. to isolate GABAA currents they bathed slices in DNQX (AMPA antagonist; 10 μM) and
strychnine (glycine receptor antagonist; 1 μM), whereas we bathed slices in picrotoxin (100 μM)
to isolate excitatory currents. The differences we see in our data compared to Nugent et al. could
be purely due to circuit-wide effects of bath application of drugs that could have broad effects on
the slices. Also, if HFS does cause a decrease in GABA release from VTA GABA neurons (via a
heterosynaptic mechanism), this could be a sort of built-in compensatory mechanism for the
decrease in excitability that HFS produces in VTA GABA neurons according to our data. This
interpretation fits results reported elsewhere, in which HFS failed to induce LTP of field
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potentials in rat brain slices devoid of ionotropic receptor antagonists (Liu et al., 2010).
Alternatively, it should be considered that the LTPGABA noted by Nugent et al. (2007) is solely
synapse specific, causing increased GABA release onto dopamine neurons directly, and not
dependent specifically on the activity level of the GABA cells. Therefore, this does not rule out
the possibility that depression of excitatory input to GABA cells that we noted could be
occurring simultaneously with LTPGABA; where overall depressed GABA neuron activity occurs
concomitantly with enhanced GABA release.
Later findings of Nugent et al. (2008) actually partially fit with the disinhibition model
and our data. However, they describe the HFS-LTP of field potentials as NMDAR-dependent,
while we describe HFS-LTD of VTA GABA neurons as CB1 receptor dependent. In truth, both
mechanisms may be at work. It was reported earlier that VTA GABA neurons have a basal
AMPA/NMDA ratio of 0.68±0.1, which indicates that NMDARs are abundant at GABA neuron
excitatory synapses (Bonci & Malenka, 1999). We did not assess whether AMPA/NMDA ratio
changes in VTA GABA neurons in response to HFS; nor did we evaluate whether HFS-LTD
occurs in the presence of APV, but doing these experiments will clarify the relative roles of CB1
receptors and NMDARs in HFS-LTD.
One plasticity study of note that affirms the inhibition model came from the group led by
Christian Lüscher. They demonstrated that medium spiny neurons (MSNs) originating in the
nucleus accumbens formed inhibitory synapses onto VTA GABA neurons, and that optogenetic
activation of these MSNs inhibited GABA neuron firing, thereby increasing VTA DA neuron
firing. They further showed that selective HFS of the MSNs (4 trains of 100 pulses at 50 Hz,
each initiated 20s apart) potentiated this inhibitory input onto VTA GABA neurons, and that this
HFS-iLTP was occluded by in vivo cocaine administration (Bocklisch et al., 2013). Our study
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differs in the inputs and the type of currents that we investigate, but we show another way in
which HFS of inputs onto VTA GABA neurons causes a long-term reduction in excitability of
the GABA neurons. Furthermore, Bocklisch et al. show the relevance that our findings have in
relation to VTA DA neurons, namely that depressing VTA GABA neuron activity will enhance
VTA DA neuron activity and increase DA release. Our findings show further support for this
disinhibition model.
Our study also verifies previous data obtained in this lab and further contextualizes how
VTA GABA cells undergo plasticity. The simplest model that could be drawn from the results in
this study is summarized in Figure 8. HFS causes high amounts of glutamate to be released from
excitatory cells onto VTA GABA neurons. The glutamate then activates group I mGluRs,
activating the PLC pathway, resulting in DAG lipase to generate 2-AG as a cleavage product of
arachidonic acid. 2-AG then diffuses to the presynaptic terminal and activates CB1, decreasing
the amount of glutamate released from the presynaptic terminal. This model fits with well-known
cellular pathways (Rao et al., 2000).
The data obtained in this study fit the model proposed above, but the factors that govern
plasticity of VTA GABA neurons are likely much more complex. Our results do not definitively
prove a causal link between HFS and mGluR activation of these neurons, nor do they
demonstrate a causal link between mGluR activation and CB1 activation. Further study can
demonstrate whether these associations exist. If a group I mGluR antagonist prevents HFS-LTD
from occurring, and if a CB1 antagonist prevents DHPG from inducing LTD, then these links
can be established.
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Endocannabinoids and CB1 in the VTA
We demonstrated that CB1 activation by 2-AG causes a long-term decrease in EPSC
amplitude in VTA GABA neurons, and we hypothesize that this process can aid in disinhibition
VTA DA neurons. We acknowledge, however, that the CB1 receptor has many functions within
the VTA that can either promote or oppose this paradigm. CB1 receptors are expressed in both
glutamatergic and GABAergic terminals in the VTA that directly input to DA neurons (Mátyás,
Urbán, & Watanabe, 2008). It has been reported that CB1 activation can depress IPSC amplitude
in VTA DA neurons (Szabo, 2002). This supports the disinhibition model, but this mechanism of
disinhibition is distinct from the one that we have found as we are examining different synapses.
Another study found that CB1R agonists cause presynaptic inhibition of EPSCs in VTA DA
neurons in the presence of picrotoxin (100 μM) (Melis et al., 2004). The findings of Melis et al.
mainly reveal only how CB1 receptor activation affects the glutamatergic synapses of DA
neurons themselves, and not how CB1 receptor activation affects the VTA at large.
Likewise, our study examines how CB1 receptor activation affects excitatory synapses of
VTA GABA neurons. More research must be performed to see how CB1 receptor activation
affects the VTA more broadly. One recent attempt at this showed that chronic in vivo activation
of CB1 receptors using the agonist HU210 occluded a form of LFS-LTD of field EPSPS (with no
ionotropic receptor antagonists) that was discovered in the VTA (Liu et al., 2010). This suggests
that chronic CB1 receptor activation actually depresses VTA DA neuron activity. The
combination of our research and the other studies summarized here shows that CB1 receptor
activation leads to reduced neurotransmitter release at many synapses in the VTA, and there are
many parallel mechanisms that determine how exogenous tampering with eCB signaling can lead
to addiction.
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The present study shows that CB1 activation is required for HFS-LTD in VTA GABA
neurons. Furthermore, the eCB 2-AG results in LTD. However, attempts at occluding HFS-LTD
with prior CB1 activation showed mixed results. What factors could explain why HFS-LTD
happened after CB1 receptors were activated for more than 10 minutes prior to HFS?
One explanation we considered as to why 2-AG did not consistently occlude HFS-LTD is
that the cells may have become sensitized to the drug. It has been observed elsewhere that acute
exposure to 2-AG can increase CB1 mRNA levels in the midbrain (Landa, Jurajda, & Sulcova,
2010). However, it is unlikely that the amount of time the slices were exposed to 2-AG was
enough for synthesis and trafficking of more CB1 receptors to the glutamatergic terminals.
Furthermore, there is considerable evidence in studies with monoacylglycerol lipase (MAGL) -/mice that overexposure of CB1 receptor-containing synapses to 2-AG actually desensitizes CB1
receptors to 2-AG (Chanda, Gao, Mark, & Btesh, 2010; Pan et al., 2011; Schlosburg et al.,
2010).
The lack of occlusion we observed might more easily be explained by experimental
variation. More replication of this experiment would show how VTA GABA neurons behave to
this protocol on average. There is still precedent for us to potentially see occlusion of HFS-LTD
by CB1 activation, because unpublished data from our lab shows that the CB1/TRPV1 agonist
R-methanandamide occludes HFS-LTD. If CB1 activation causes maximal LTD, then we would
expect both R-meth and 2-AG to occlude further LTD via HFS. We acknowledge the possibility
that more than one plasticity mechanism may be at work at this synapse. The HFS-LTD we
observed may partially be due to NMDAR activity or that of another receptor, notwithstanding
that our AM-251 results show that CB1 receptor activation is required for HFS-LTD.
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VTA GABA Neurons, CB1 Receptors, and Addiction
VTA GABA neurons play an important role in motivation and reward by disinhibiting
VTA dopamine cells, and there are many ways in which VTA GABA neurons can be modulated
in both normal activity and addictive processes. It has been reported that VTA GABA neurons
disrupt reward consumption (van Zessen et al., 2012) and mediate conditioned place aversion
(Tan et al., 2012). The current study focuses on synapses onto VTA GABA neurons themselves
specifically, but not the outputs of these neurons. These GABA neurons synapse not only onto
local DA neurons, but also onto neurons in the nucleus accumbens where they can alter reward
and associative learning (Brown et al., 2012; Johnson & North, 1992). These GABAergic
terminals are then subject to further modification in order to fine-tune their firing rates. For
example, drugs such as cocaine and nicotine can abolish potentiation of GABAergic inputs onto
DA neurons, in turn increasing DA levels in the mesocorticolimbic system (Niehaus, Murali, &
Kauer, 2010). Thus VTA GABA neurons play an important role in the reward pathway.
CB1 receptors have been demonstrated to be directly or indirectly involved in reward
pathway and addiction as well. CB1 receptors are prevalent throughout the brain, and in the VTA
they are present in both excitatory and inhibitory axon terminals (Kortleven et al., 2011; Mátyás
et al., 2008; Pan et al., 2008b). Although CB1 receptors are directly activated by THC, other
drugs can exert their effects indirectly through CB1 receptors. Conditioned place preference
(CPP) studies with rats showed that activation of CB1 in the VTA enhances the ability of
morphine to induce CPP in mice, and that blocking CB1 receptors in the VTA diminishes CPP
induced by morphine (Rashidy-Pour et al., 2013). While morphine does not directly bind to CB1
receptors, its effects on the neural network of the VTA may result in CB1 activation, which will
cause LTD in VTA GABA neurons and disinhibit VTA DA neurons. Additionally,
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pharmacological inhibition of the synaptic breakdown of the eCB anandamide will enhance the
increase of VTA DA release caused by cocaine administration in mice, which shows that CB1
activation enhances the effects of cocaine in the VTA (Mereu et al., 2013). Therefore, future
examination of the CB1-dependent plasticity reported here, in combination with various drugs of
abuse, could provide a link between this pathway and addiction.
Significance
The results of the present study shed more light on how the population of VTA GABA
neurons, an important hub in the brain’s reward circuit, can be affected in the long term by
upstream excitatory activity. This study specifically addresses a potential mechanism whereby
marijuana could exert its addictive effects. This is important because although marijuana
addiction has a high prevalence among illicit drugs (Kandel, Chen, Warner, Kessler, & Grant,
1997), it remains difficult to treat partly because its addictive mechanisms are poorly understood
(Elkashef, Vocci, & Huestis, 2008). This study shows how both glutamatergic activity and
cannabinoid receptor activation are tied to LTD of VTA GABA neurons. These events can lead
to disinhibition of VTA DA neurons. The resulting increase of DA in the VTA and its
projections in turn could mediate rewarding and addictive behavior.
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FUTURE DIRECTIONS
The data obtained support the hypothesis that CB1 receptors are intimately involved in
the plasticity of VTA GABA neurons. However, due to the lipophilic nature of drugs and
endogenous molecules that bind to CB1 receptors, the results we have collected may not be
definitive. Performing similar experiments on CB1 knockout mice will provide important genetic
cross-validation to our current results, and may broaden our understanding of the mechanisms
whereby CB1 receptors are normally activated. We have already shown that activation of group I
mGluRs results in LTD of VTA GABA neurons, but we haven’t directly linked mGluR
activation with CB1 activation. CB1 KO mice will help to establish whether or not there is a
causal link between these two types of receptors.
The results from this study also set the stage for studying THC, a mild drug of abuse
(Haney, Comer, Ward, Foltin, & Fischman, 1997). Because CB1 receptors are involved in VTA
GABA neuron plasticity, and these neurons are important in reward circuits, VTA GABA
neurons may be important substrates that mediate the addictive effects of THC. The experiments
conducted with 2-AG in this study should be replicated using THC to see if the drug can cause
LTD via CB1 activation. Another experiment with more physiological importance would be to
inject mice with THC and examine how the drug affects plasticity in VTA GABA neurons either
24 hours later or several days after administration. It will eventually be important to know how
antagonists or modulators of CB1 receptors can mitigate the effects THC injection may have on
plasticity.
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FIGURE LEGENDS
Figure 1: Control EPSC Amplitudes Stay Constant over Time and Currents are mediated by
Glutamate Receptors. A) EPSC Amplitudes Stay Constant over Time. Bath application of control
ACSF (Same as the ACSF that was already in the bath) for 10 minutes does not cause EPSC
amplitudes to diminish. EPSC amplitudes may begin to lessen after 45 minutes of establishing
cell opening. Black bar indicates time period when second solution of control ACSF was present
in bath. Inset: EPSC traces from whole cell recording of VTA GABA cell. Black trace is baseline
and red trace is 28-30 minutes after application of control ACSF, scale bar: 100 pA, 10 ms. B)
Bath application of APV (NMDAR antagonist, 50 μM) and CNQX (AMPAR antagonist, 10 μM)
completely extinguish EPSCs, and EPSC amplitude partially recovers after resuming control
ACSF. This shows that the currents isolated were completely mediated by glutamate-gated ion
channels. Note that all solutions of ACSF already contained the GABAA antagonist picrotoxin
(100 μM). Black bar indicates the time period when solution containing APV and CNQX was
applied to bath. Inset: EPSC traces from whole cell recording of VTA GABA cell. Black trace is
baseline and red trace is 10-15 minutes after application of conditioning ACSF, scale bar: 100
pA, 10 ms.
Figure 2: High Frequency Stimulation (HFS) Mediates LTD in VTA GABA neurons, most likely
in a presynaptic manner. A) VTA GABA neurons undergo LTD after HFS treatment (p=0.0098;
n=17). Arrow indicates time of HFS. Error bars indicate standard error of the mean (SEM). Inset:
representative EPSC traces from whole cell recordings of VTA GABA cells. Black trace is
baseline and red trace is 28-30 minutes post-HFS, scale bar: 100 pA, 10 ms. B) HFS-LTD
increases paired pulse ratio (PPR) (NS: p=0.203; n=9) and decreases 1/(coefficient of variation)2
(1/CV2) (NS: p=0.074; n=9). PPR increased in 7 of 9 cells and 1/CV2 decreased in 8 of 9 cells.
Open squares indicate values from individual experiments; closed squares represent average
values.
Figure 3: TRPV1 Antagonist Capsazepine Fails to Block HFS-LTD. When slices were
preconditioned in ACSF containing capsazepine (10 μM), LTD still occurred after HFS
(p=0.016; n=9). Black bar indicates time period that capsazepine was present in bath. Arrow
indicates time of HFS. Error bars indicate SEM. Inset: representative EPSC traces from whole
cell recordings of VTA GABA cells. Black trace is baseline and red trace is 28-30 minutes after
HFS, scale bar: 100 pA, 10 ms.
Figure 4: CB1 Receptor Antagonist AM-251 prevents HFS-LTD in VTA GABA neurons.
Blockade of CB1 receptors by AM-251 (2 μM) results in no significant change in EPSC
amplitude (p=0.81; n=3) in response to HFS (arrow). Error bars indicate SEM.
Inset: representative EPSC traces from whole cell recordings of VTA GABA cells. Black trace is
baseline and red trace is 28-30 minutes after HFS, scale bar: 100 pA, 10 ms.
Figure 5: 2-AG Mediates LTD of VTA GABA Neurons Via a Presynaptic Mechanism. A)
Application of CB1 agonist 2-AG (25 μM, 0.1% DMSO) for 10 minutes induces a significant
depression of EPSC amplitude (p=0.035; n=6) that is long-term. Black bar indicates the period of
time that 2-AG was applied to the bath. Error bars indicate SEM.
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Inset: representative EPSC traces from whole cell recordings of VTA GABA cells. Black trace is
baseline and red trace is post-HFS, scale bar: 100 pA, 10 ms. B) LTD induced by 2-AG
coincides with an increased PPR (NS: p=0.125; n=4) and a decreased 1/CV2 (NS: p=0.125; n=4).
Though not statistically significant, the trend observed so far indicates a presynaptic mechanism
for LTD. PPR increased in 4 of 4 cells and 1/CV2 decreased in 4 of 4 cells. Open squares
indicate values from individual experiments; closed squares represent average values.
Figure 6: LTD Mediated by 2-AG Does Not Fully Occlude Further LTD by HFS. HFS in slices
pre-conditioned with CB1 receptor agonist 2-AG (25 μM, 0.1% DMSO) resulted in LTD. Not
enough full-length experiments were collected to perform statistical analysis. Only 1 of 3
experiments showed no change in response to HFS. Black bar indicates time period during which
2-AG was present in the bath. Arrow indicates time of HFS. Error bars indicate SEM. Inset:
representative EPSC traces from whole cell recordings of VTA GABA cells. Black trace is
baseline and red trace is 10-15 minutes after HFS, scale bar: 100 pA, 10 ms.
Figure 7: DHPG Causes LTD in VTA GABA Neurons. A) Robust LTD occurs (p=0.0019; n=5)
soon after application of DHPG (100 μM) for 10 minutes. Black bar indicates time period that
DHPG was applied to the bath. Error bars indicate SEM. Inset: representative EPSC traces from
whole cell recordings of VTA GABA cells. Black trace is baseline and red trace is post-HFS,
scale bar: 100 pA, 10 ms. B) LTD caused by DHPG coincides with an increased PPR (NS:
p=0.250; n=4) and a decreased 1/CV2 (NS: p=0.125; n=4). Though not statistically significant,
the trend observed so far indicates a presynaptic mechanism for LTD. PPR increased in 3 of 4
cells and 1/CV2 decreased in 4 of 4 cells. Open squares indicate values from individual
experiments; closed squares represent average values.
Figure 8: Proposed Model for HFS-mediated LTD in VTA GABA Neurons. High frequency
stimulation allows glutamate to accumulate in the synapse until activation of perisynaptic type I
mGluRs occurs. Intracellular signaling downstream of mGluR activation results in synthesis of
2-AG within the VTA GABA neuron. 2-AG diffuses across the synapse to the terminal of
glutamatergic neurons and activate CB1 receptors. This activation triggers intracellular signaling
within the terminal that results in diminished glutamate release. Adapted by permission from
Macmillan Publishers Ltd: Nature Reviews Neuroscience (Kauer & Malenka), copyright 2007.
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Figure 1B: EPSCs are Fully Attenuated by Antagonists APV and CNQX.
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